Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.


Ozguroglu M., Oudard S., Sartor A. O., Hansen S., Machiels J. H., Shen L., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.29, sa.15, 2011 (SCI-Expanded) identifier